SHIELD THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.35 GBX | +10.20% |
|
-8.47% | -79.85% |
| 22/02 | Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024 | |
| 21/02 | FTSE 100 takes hit ahead of FOMC minutes | AN |
Quotes 5-day view
Delayed Quote London S.E.| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | |
|---|---|---|---|---|
| Last | 1.425 p | 1.325 p | 1.225 p | 1.35 p |
| Volume | 700 061 | 2 958 047 | 8 963 337 | 8 345 835 |
| Change | 0.00% | -7.02% | -7.55% | +10.20% |
| Opening | 1.43 | 1.43 | 1.33 | 1.23 |
| High | 1.43 | 1.45 | 1.31 | 1.40 |
| Low | 1.40 | 1.30 | 1.06 | 1.20 |
Performance
| 1 day | +10.20% | ||
| 1 week | -8.47% | ||
| Current month | -33.33% | ||
| 1 month | -32.50% | ||
| 3 months | -78.40% | ||
| 6 months | -77.12% | ||
| Current year | -79.85% | ||
| 1 year | -80.77% | ||
| 3 years | -96.93% | ||
| 5 years | -98.51% |
Volumes
marketsDaily volume
8 160 121
Estimated daily volume
8 160 121
Avg. Volume 20 sessions
3 724 098
Daily volume ratio
2.19
Avg. Volume 20 sessions GBX
5 027 532.30
Avg. Volume 20 sessions USD
5 027 532.30
Record volume 1
165 039 100
Record volume 2
50 925 440
Record volume 3
38 827 200
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (GBX)
10 529 679
Capitalization (USD)
13 150 516
Net sales (GBP)
4 467 000
Net sales (USD)
5 578 836
Number of employees
27
Sales / Employee (GBP)
165 444
Sales / Employee (USD)
206 624
Free-Float
43.82 %
Free-Float capitalization (GBX)
4 614 279
Free-Float capitalization (USD)
5 762 773
Average Daily Capital Traded
47.75%
Highs and lows
1 week
1.06
1.50
1 month
1.062.10
Current year
1.067.80
1 year
1.0612.85
3 years
1.0662.60
5 years
1.06202.00
10 years
1.06202.00
Indicators
Moving average 5 days
1.35
Moving average 20 days
1.61
Moving average 50 days
2.40
Moving average 100 days
4.39
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
+19.12%
Price spread / (MMA50)
+77.99%
Price spread / (MMA100)
+224.93%
STIM
RSI 9 days
6.93
RSI 14 days
12.17
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.20% | -8.47% | -79.85% | -80.77% | 13.15M | ||
| -0.06% | +0.81% | -2.31% | +17.12% | 103B | ||
| -0.84% | -1.52% | +0.56% | +11.47% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +1.90% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.94% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.08% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.05% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.89% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +33.45% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.44% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.18% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +278.94% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +76.54% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +49.70% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -71.56% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +30.43% | 6.99B | ||
| Average | +2.24% | +3.25% | +6.33% | +11.97% | ||
| Weighted average by Cap. | +0.59% | +1.87% | +2.08% | +10.62% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
f7b6ae785b6f8c.7T1q9ZJ329ZbHUMqew7Wgmq5XEuixjZrqANbbCmpQMw.gkQjmNdCubE_LhxFQn2csDnwOj7V82407zpiJW-fEr60SQPYpkCCsQFQNA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 08:56:42 pm | 1.4 | 15,000 | 8,160,121 |
| 08:55:57 pm | 1.394 | 588,235 | 8,145,121 |
| 08:49:49 pm | 1.349 | 88,587 | 7,556,886 |
| 08:29:41 pm | 1.35 | 25,000 | 7,468,299 |
| 08:27:45 pm | 1.35 | 100,000 | 7,443,299 |
| 08:27:20 pm | 1.347 | 593,466 | 7,343,299 |
| 08:26:35 pm | 1.34 | 521,940 | 6,749,833 |
| 08:16:31 pm | 1.265 | 590 | 6,227,893 |
| 08:10:58 pm | 1.3 | 100,000 | 6,227,303 |
Monthly variations
Annual change
| 2024 | -79.85% | ||
| 2023 | -4.96% | ||
| 2022 | -84.16% | ||
| 2021 | -29.92% | ||
| 2020 | -64.53% | ||
| 2019 | +486.89% | ||
| 2018 | -72.89% | ||
| 2017 | -34.97% | ||
| 2016 | +10.19% |
- Stock Market
- Equities
- STX Stock
- Quotes Shield Therapeutics plc
